|
Index of reports
> Disability (28)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kaletra (Lopinavir / Ritonavir) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Kaletra side effects in male
Reported by a physician from Japan on 2012-08-24
Patient: male, weighing 59.5 kg (130.9 pounds)
Reactions: Pulmonary Hypertension, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Nausea, Tremor, Palpitations, Visual Impairment, Dizziness, Nervous System Disorder, Influenza Like Illness
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Abacavir Sulfate
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Abacavir Sulfate
Administration route: Oral
Start date: 2001-10-20
End date: 2001-10-27
Didanosine
Administration route: Oral
Start date: 2001-07-21
End date: 2004-05-14
Didanosine
Administration route: Oral
Indication: HIV Infection
Start date: 1994-11-19
End date: 2001-07-21
Efavirenz
Administration route: Oral
Start date: 2000-09-25
End date: 2000-10-02
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Indinavir
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-08
End date: 2000-05-24
Kaletra
Administration route: Oral
Indication: HIV Infection
End date: 2004-04-24
Lamivudine
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
End date: 2008-09-19
Norvir
Administration route: Oral
Start date: 2008-09-20
Norvir
Administration route: Oral
Start date: 2004-04-25
End date: 2008-09-19
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Peginterferon Alfa-2B
Indication: Hepatitis C
Start date: 2002-08-17
End date: 2003-07-12
Saquinavir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-03-18
Saquinavir
End date: 2001-03-31
Saquinavir
Administration route: Oral
Start date: 2000-05-24
End date: 2000-12-24
Stavudine
Dosage: daily
Administration route: Oral
Indication: HIV Infection
Start date: 1997-08-25
End date: 2001-10-20
Other drugs received by patient: Truvada; Amlodipine Besylate; Lexiva; Coagulation Factor Viii; Olmesartan Medoxomil; Tenofovir Disoproxil Fumarate; Isentress; Cross Eight M; Ribavirin; Coagulation Factor Viii; Ribavirin; Atazanavir
Possible Kaletra side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Diabetes Mellitus, Hypertriglyceridaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Epivir
Dosage: 150 mg, bid
Administration route: Oral
Indication: HIV Infection
Start date: 2003-09-16
End date: 2006-02-28
Epivir
Dosage: 150 mg, bid
Administration route: Oral
Start date: 2008-12-16
Intelence
Dosage: 200 mg, bid
Administration route: Oral
Indication: HIV Infection
Start date: 2009-02-11
Isentress
Dosage: 800 mg divided dose frequency u
Administration route: Oral
Start date: 2008-08-05
Kaletra
Dosage: 4 df
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-04
End date: 2008-01-08
Prezista
Dosage: 1200 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-09
End date: 2008-05-01
Truvada
Dosage: 1 df, unk
Administration route: Oral
Start date: 2008-08-05
End date: 2008-12-15
Truvada
Dosage: 1df
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-04
End date: 2008-05-01
Zerit
Dosage: 60 mg divided dose frequency u
Administration route: Oral
Start date: 2008-12-16
End date: 2009-02-10
Zerit
Dosage: 80 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2003-09-16
End date: 2006-02-28
Other drugs received by patient: Rhythmy
Possible Kaletra side effects in 24 year old male
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient: 24 year old male
Reactions: Pulmonary Hypertension, Palpitations, Dizziness
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Crixivan
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Efavirenz
Dosage: interrupted from 07/25/00 to 09/25/00 24jul-25jul2000,25sep-02oct2000. film coated tab 200 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-10-02
Epivir
Dosage: tabs
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
End date: 2008-09-19
Invirase
Dosage: inter:03/18/00-05/24/00,caps 800mg:19jun99-18mar2000.divided dse:24may00-24dec2000,19jun1999-24dc00
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2001-03-31
Kaletra
Dosage: 1df,25dec2000-24apr2004:1217 days
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Norvir
Dosage: 31mar2001(interrupted).caps 800mg:19jun99-31oct-99.divided dose:01nov99-24dec2000.25apr2004
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2008-09-19
Videx
Dosage: 250,300,400mg12/19/94-3/7/97,3/07/97-7/21/01,7/21/01,125mg,19dc94-7mar97(810d),7mr97-21jl01(1598d)
Administration route: Oral
Indication: HIV Infection
Start date: 1994-12-19
End date: 2001-07-21
Videx EC
Dosage: divided dose
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-21
End date: 2004-05-14
Zerit
Dosage: 60 mg 8/25/97-27/2/98, 80 mg 2/27-8/3/98, 11/9/98 -6/19/99 and 12/25/00-10/20/01
Administration route: Oral
Indication: HIV Infection
Start date: 1997-08-25
End date: 2001-10-20
Ziagen
Dosage: interrupted from 07/25/00 to 10/20/01 tabs24jul-25jul2000.20oct2001-27oct2001.
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2001-10-27
Other drugs received by patient: Cross Eight M
Possible Kaletra side effects in male
Reported by a physician from Japan on 2012-08-01
Patient: male
Reactions: Hepatitis C
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2007-12-20
Kaletra
Other drugs received by patient: Didanosine; Didanosine; Tenofovir Disoproxil Fumarate
Possible Kaletra side effects in 59 year old male
Reported by a physician from Japan on 2012-07-10
Patient: 59 year old male
Reactions: LIP Swelling, Hypersensitivity, Rash Generalised, Stomatitis, Blood Triglycerides Increased, Oropharyngeal Pain
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Abacavir
Administration route: Oral
Indication: HIV Infection
Start date: 2008-07-18
End date: 2008-07-27
Abacavir
Start date: 2008-07-29
Kaletra
Administration route: Oral
Start date: 2008-07-29
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2008-07-18
End date: 2008-07-27
Lamivudine
Administration route: Oral
Indication: HIV Infection
Start date: 2008-07-18
End date: 2008-07-27
Lamivudine
Start date: 2008-07-29
Other drugs received by patient: Tenofovir Disoproxil Fumarate; Metoclopramide; Sulfamethoxazole and Trimethoprim; Loperamide HCL
Possible Kaletra side effects in 20 year old male
Reported by a health professional (non-physician/pharmacist) on 2012-06-29
Patient: 20 year old male, weighing 73.0 kg (160.6 pounds)
Reactions: Neutropenia, Ill-Defined Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cidofovir
Dosage: 52.8571 mg (370 mg, 1 in 1 wk), intravenous
Indication: JC Virus Infection
Start date: 2012-03-28
End date: 2012-04-23
Cidofovir
Dosage: 52.8571 mg (370 mg, 1 in 1 wk), intravenous
Indication: Progressive Multifocal Leukoencephalopathy
Start date: 2012-03-28
End date: 2012-04-23
Kaletra
Dosage: 4 dosage forms (2 dosage forms, 2 in 1 d), oral
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-14
Zidovudine
Dosage: 500 mg (250 mg, 2 in 1 d), oral
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-14
End date: 2012-04-06
Other drugs received by patient: Probenecid; Mirtazapine; Saquinavir (Saquinavir); Tenofovir (Tenofovir)
Possible Kaletra side effects in 20 year old male
Reported by a pharmacist from United Kingdom on 2012-06-28
Patient: 20 year old male
Reactions: Neutropenia, Ill-Defined Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Dosage: 2 df, bid
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-14
Vistide
Dosage: 370 mg, q1wk
Indication: Progressive Multifocal Leukoencephalopathy
Start date: 2012-03-28
End date: 2012-04-23
Vistide
Indication: JC Virus Infection
Zidovudine
Dosage: 250 mg, bid
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-14
End date: 2012-04-06
Other drugs received by patient: Saquinavir; Tenofovir Disoproxil Fumarate; Probenecid; Mirtazapine; Probenecid; Probenecid
Possible Kaletra side effects in 20 year old male
Reported by a pharmacist from United Kingdom on 2012-06-27
Patient: 20 year old male, weighing 73.0 kg (160.6 pounds)
Reactions: Neutropenia, Ill-Defined Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cidofovir
Dosage: 370mg weekly
Indication: Progressive Multifocal Leukoencephalopathy
Start date: 2012-03-28
End date: 2012-04-23
Cidofovir
Indication: JC Virus Infection
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-14
Zidovudine
Dosage: 250mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-14
End date: 2012-04-06
Other drugs received by patient: Saquinavir; Probenecid; Mirtazapine; Tenofovir Disoproxil Fumarate
Possible Kaletra side effects in male
Reported by a physician from Japan on 2012-06-26
Patient: male
Reactions: Osteonecrosis, Epilepsy, Extradural Haematoma
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Efavirenz
Dosage: 600 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Epivir
Dosage: 300 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Kaletra
Dosage: 4 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-24
End date: 2008-10-27
Kaletra
Dosage: 6 df, qd
Administration route: Oral
Start date: 2002-11-24
End date: 2006-10-23
Prezista
Dosage: 1200 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2008-10-28
End date: 2010-05-18
Ritonavir
Dosage: 200 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2008-10-28
End date: 2010-05-18
Tenofovir Disoproxil Fumarate
Administration route: Oral
Indication: HIV Infection
Start date: 2002-11-25
Zerit
Dosage: 80 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Other drugs received by patient: Clonazepam; Bufferin; Primidone; Primidone; Anafranil; Bromvalerylurea; Loperamide Hydrochloride; Ganaton; Depakene; LAC B; Merislon
Possible Kaletra side effects in male
Reported by a physician from Canada on 2012-05-30
Patient: male, weighing 55.4 kg (121.9 pounds)
Reactions: Weight Decreased, Dysphagia, Wrong Technique in Drug Usage Process, Gastric Operation, Oesophageal Carcinoma, Abdominal Discomfort, Oesophageal Food Impaction, Oesophagectomy
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Dosage: 200 mg/ 50 mg, 2 tabs in 1 day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-23
Kaletra
Indication: Antiretroviral Therapy
Kaletra
Indication: HIV Infection
End date: 2012-02-13
Kaletra
Indication: Antiretroviral Therapy
Other drugs received by patient: Truvada; Viread; Aspirin; Viramune; Metoprolol Tartrate; Lipitor
Possible Kaletra side effects in 52 year old male
Reported by a physician from United Kingdom on 2012-05-07
Patient: 52 year old male, weighing 68.0 kg (149.6 pounds)
Reactions: Weight Decreased, Renal Cancer Metastatic, Lymphadenopathy, Lung Neoplasm, Renal Mass, Metastases To Bone, Metastases To Lung
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Abacavir Sulfate / Lamivudine; Opioids; Analgesia
Possible Kaletra side effects in 52 year old male
Reported by a physician from United Kingdom on 2012-05-02
Patient: 52 year old male, weighing 68.0 kg (149.6 pounds)
Reactions: Weight Decreased, Renal Cancer Metastatic, Lymphadenopathy, Lung Neoplasm, Metastases To Bone, Renal Mass, Metastases To Lung
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Analgesia; Abacavir Sulfate / Lamivudine; Opioids
Possible Kaletra side effects in male
Reported by a physician from France on 2012-03-26
Patient: male
Reactions: Aphasia, Hemiplegia, Cerebrovascular Accident
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Kaletra
Dosage: 250mg/50mg
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Other drugs received by patient: Crestor
Possible Kaletra side effects in male
Reported by a physician from France on 2012-03-23
Patient: male
Reactions: Cerebrovascular Accident
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Dosage: 1unit per day
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Kaletra
Dosage: 4unit per day
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Viread
Dosage: 1unit per day
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Other drugs received by patient: Crestor
Possible Kaletra side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-21
Patient: male
Reactions: Cerebrovascular Accident
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Kaletra
Dosage: 4 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Viread
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2007-07-05
Other drugs received by patient: Crestor
Possible Kaletra side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-19
Patient: male
Reactions: Optic Atrophy, Glaucoma, Trigeminal Neuralgia, Visual Acuity Reduced, Optic Neuritis, Treatment Noncompliance, Optic Neuropathy, Mononeuropathy, AIDS Encephalopathy, Balance Disorder, Leukoencephalopathy, Viral Load Increased, Visual Field Defect, Mass, Viral Load Decreased, Psoriasis, Scotoma, Toxicity To Various Agents, Sensory Disturbance, Visual Impairment, CD4 Lymphocytes Abnormal, Memory Impairment, Asthenia, Anogenital Warts, Neuralgia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamprenavir Calcium
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2005-03-29
End date: 2006-06-23
Gabapentin
Administration route: Oral
Indication: Trigeminal Neuralgia
Start date: 2006-01-01
Kaletra
Start date: 2003-01-03
Kaletra
Start date: 2003-09-12
Kaletra
Indication: HIV Infection
Start date: 2000-09-01
Lamivudine + Zidovudine
End date: 2006-06-23
Lamivudine + Zidovudine
Start date: 2001-03-23
Lamivudine + Zidovudine
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-05-11
End date: 1999-08-01
Lamivudine + Zidovudine
Start date: 2005-09-28
Norvir
Start date: 2002-03-18
Norvir
Start date: 2004-04-17
Norvir
Start date: 2004-10-15
Norvir
Start date: 2005-09-28
Norvir
Start date: 2005-03-29
Norvir
Start date: 2006-06-23
Norvir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1999-09-21
Norvir
Start date: 2005-06-17
Norvir
Start date: 2000-06-06
Norvir
Start date: 2001-03-23
Pregabalin
Administration route: Oral
Indication: Trigeminal Neuralgia
Start date: 2006-06-23
End date: 2006-07-13
Saquinavir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1997-03-19
Saquinavir
Start date: 2006-06-23
Sulfamethoxazole + Trimethoprim
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 1998-09-01
Sulfamethoxazole + Trimethoprim
Start date: 2002-03-18
Sulfamethoxazole + Trimethoprim
Start date: 2005-09-28
Sulfamethoxazole + Trimethoprim
Start date: 2006-06-23
Sulfamethoxazole + Trimethoprim
Start date: 1998-10-27
Tenofovir Disoproxil Fumarate
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2002-03-18
Tenofovir Disoproxil Fumarate
Start date: 2003-01-03
Tenofovir Disoproxil Fumarate
Start date: 2003-09-12
Tenofovir Disoproxil Fumarate
Start date: 2005-06-17
Tenofovir Disoproxil Fumarate
Start date: 2006-06-23
Tenofovir Disoproxil Fumarate
Start date: 2004-04-17
Tenofovir Disoproxil Fumarate
Start date: 2004-10-15
Tenofovir Disoproxil Fumarate
Start date: 2005-09-28
Tenofovir Disoproxil Fumarate
Start date: 2005-03-29
Zidovudine
Start date: 2006-06-23
Zidovudine
Start date: 2005-09-28
Zidovudine
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1992-01-01
End date: 1997-01-01
Zidovudine
Start date: 2005-06-17
Other drugs received by patient: Stavudine; Didanosine; Lamivudine; Atazanavir; Stavudine; Indinivir Sulfate; Indinivir Sulfate; Didanosine; Didanosine; Amprenavir; Stavudine; Stavudine; Didanosine; Amprenavir; Atazanavir; Cyamemazine; Didanosine; Enfuvirtide; Enfuvirtide; Stavudine; Stavudine; Stavudine; Indinivir Sulfate; Abacavir; Amitriptyline HCL; Lamivudine; Amprenavir; Amprenavir
Possible Kaletra side effects in male
Reported by a consumer/non-health professional from Japan on 2012-02-07
Patient: male
Reactions: Osteonecrosis, Epilepsy
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Efavirenz
Dosage: 600 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Epivir
Dosage: 300 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Kaletra
Dosage: 6 df, qd
Administration route: Oral
Start date: 2002-11-24
End date: 2006-10-23
Kaletra
Dosage: 4 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-24
End date: 2008-10-27
Prezista
Dosage: 1200 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2008-10-28
End date: 2010-05-18
Ritonavir
Dosage: 200 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2008-10-28
End date: 2010-05-18
Tenofovir Disoproxil Fumarate
Administration route: Oral
Indication: HIV Infection
Start date: 2002-11-25
Zerit
Dosage: 80 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Other drugs received by patient: Primidone; Depakene; Bufferin; Clonazepam; Bromvalerylurea; Merislon; LAC B; Primidone; Loperamide HCL; Ganaton; Anafranil
Possible Kaletra side effects in male
Reported by a physician from Japan on 2012-02-01
Patient: male
Reactions: Osteonecrosis, Epilepsy
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Efavirenz
Dosage: 600 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Epivir
Dosage: 300 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Kaletra
Dosage: 4 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2006-10-24
End date: 2008-10-27
Kaletra
Dosage: 6 df, qd
Administration route: Oral
Start date: 2002-11-24
End date: 2006-10-23
Prezista
Dosage: 1200 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2008-10-28
End date: 2010-05-18
Ritonavir
Dosage: 200 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2008-10-28
End date: 2010-05-18
Tenofovir Disoproxil Fumarate
Administration route: Oral
Indication: HIV Infection
Start date: 2002-11-25
Zerit
Dosage: 80 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2001-02-05
End date: 2002-11-23
Other drugs received by patient: Primidone; Depakene; Bufferin; LAC B; Anafranil; Bromvalerylurea; Loperamide HCL; Merislon; Primidone; Clonazepam; Ganaton
Possible Kaletra side effects in male
Reported by a physician from Mexico on 2012-01-16
Patient: male
Reactions: Weight Decreased, Drug Resistance, Dyslipidaemia, Diarrhoea, Faecal Incontinence, Kaposi's Sarcoma
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Enterogermina; Truvada; Calcium Carbonate
Possible Kaletra side effects in male
Reported by a physician from France on 2012-01-13
Patient: male
Reactions: Confusional State, Blood Creatine Phosphokinase Increased, Dreamy State, Quality of Life Decreased, Coma, Corneal Disorder, Eye Infection, Abdominal Pain Upper, Overdose, Bronchial Disorder, Hypoxia, Oral Mucosa Erosion, Stevens-Johnson Syndrome, Renal Disorder, Toxic Epidermal Necrolysis, Cardiogenic Shock, Odynophagia, Nosocomial Infection, Eye Pain, Anxiety, Lung Disorder, Dysuria, Pharyngeal Erosion, DRY Eye
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Dosage: 200/50mg
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-05
End date: 2008-03-06
Truvada
Dosage: 200mg/245mg
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-05
End date: 2008-03-06
Other drugs received by patient: Primperan TAB; Magnesium Hydroxide TAB; Alprazolam; Raltegravir; Gaviscon; PPI; Maraviroc; Enfuvirtide; Acetaminophen; Aspirin
Possible Kaletra side effects in male
Reported by a physician from France on 2011-12-16
Patient: male
Reactions: Confusional State, Blood Creatine Phosphokinase Increased, Dreamy State, Quality of Life Decreased, Coma, Corneal Disorder, Eye Infection, Abdominal Pain Upper, Overdose, Bronchial Disorder, Hypoxia, Oral Mucosa Erosion, Stevens-Johnson Syndrome, Renal Disorder, Toxic Epidermal Necrolysis, Nosocomial Infection, Odynophagia, Cardiogenic Shock, Eye Pain, Anxiety, Lung Disorder, Dysuria, Pharyngeal Erosion, DRY Eye
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Dosage: 200/50mg (unit dose)
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-05
End date: 2008-02-28
Truvada
Dosage: 200mg/245mg (unit dose)
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-05
End date: 2008-02-28
Other drugs received by patient: Raltegravir; Maraviroc; Primperan TAB; Magnesium Hydroxide TAB; Aspirin; PPI; Enfuvirtide; Gaviscon; Acetaminophen
Possible Kaletra side effects in male
Reported by a physician from Japan on 2011-12-13
Patient: male
Reactions: Pulmonary Hypertension, Hepatic Function Abnormal, Fibrin Degradation Products Increased, Nausea, Tremor, Palpitations, Visual Impairment, Nervous System Disorder, Dizziness, Influenza Like Illness
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Abacavir Sulfate
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Abacavir Sulfate
Administration route: Oral
Start date: 2001-10-20
End date: 2001-10-27
Didanosine
Administration route: Oral
Start date: 2001-07-21
End date: 2004-05-14
Didanosine
Administration route: Oral
Indication: HIV Infection
Start date: 1994-11-19
End date: 2001-07-21
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Efavirenz
Administration route: Oral
Start date: 2000-09-25
End date: 2000-10-02
Indinivir Sulfate
Indication: HIV Infection
Start date: 2000-03-08
End date: 2000-05-24
Kaletra
Administration route: Oral
Indication: HIV Infection
End date: 2004-04-24
Lamivudine
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
End date: 2008-09-19
Norvir
Administration route: Oral
Start date: 2004-04-25
End date: 2008-09-19
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Norvir
Administration route: Oral
Start date: 2008-09-20
Peginterferon Alfa-2B
Indication: Hepatitis C
Start date: 2002-08-17
End date: 2003-07-12
Saquinavir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-03-18
Saquinavir
Administration route: Oral
Start date: 2000-05-24
End date: 2000-12-24
Stavudine
Administration route: Oral
Indication: HIV Infection
Start date: 2001-04-01
End date: 2001-10-20
Other drugs received by patient: Ribavirin; Isentress; Amlodipine Besylate; Coagulation Factor Viii; Lexiva; Olmesartan Medoxomil; Tenofovir; Coagulation Factor Viii; Ribavirin; Atazanavir; Truvada
Possible Kaletra side effects in 24 year old male
Reported by a consumer/non-health professional from United States on 2011-12-07
Patient: 24 year old male
Reactions: Pulmonary Hypertension, Palpitations, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dizziness
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Crixivan
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Efavirenz
Dosage: 24-25jul00(2d)-600mg 25sep00-02oct00(8d)
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-10-02
Epivir
Dosage: tab
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
End date: 2008-09-19
Invirase
Dosage: caps; 19jun99-18mar00(274d) 24may00-24dec00(215d)800mg
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-12-24
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Norvir
Dosage: 19jun-31oct99;400mg 01nov99-24dec00;420d 100mg/d 24apr05-19sep08;1244d 200mg/d 20sep08-cont
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
Videx
Dosage: 19dec94-7mar97(125mg)810d 8mar97-21jul01(300mg)1597d 22jul-14may04(400mg)1028d
Administration route: Oral
Indication: HIV Infection
Start date: 1994-11-19
End date: 2004-05-14
Zerit
Dosage: 25aug97-27feb98(187d) 27feb-03aug98(158) 3aug-9nov(99) 9nov98-19jn99(223) 25dc00-20oc01(300d)
Administration route: Oral
Indication: HIV Infection
Start date: 1997-08-25
End date: 2001-10-20
Ziagen
Dosage: 24jul-25jul00(2d)600mg 20oct-27oct01(8d)600mg interrupted on 25jul00
Administration route: Oral
Start date: 2000-07-24
End date: 2001-10-27
Other drugs received by patient: Cross Eight M
Possible Kaletra side effects in 24 year old male
Reported by a individual with unspecified qualification from Japan on 2011-12-06
Patient: 24 year old male
Reactions: Pulmonary Hypertension, Palpitations, Dizziness, Apparent Life Threatening Event
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Crixivan
Dosage: 800 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-18
End date: 2000-05-24
Efavirenz
Dosage: 600 mg/daily po ; 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-09-25
End date: 2000-10-02
Efavirenz
Dosage: 600 mg/daily po ; 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Invirase
Dosage: 400 mg/bid po ; 800 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 2000-03-18
Invirase
Dosage: 400 mg/bid po ; 800 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-05-24
End date: 2000-12-24
Kaletra
Dosage: 6 dose/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2004-04-24
Lamivudine
Dosage: 300 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2004-05-15
End date: 2008-09-19
Norvir
Dosage: 400 mg/bid po ; 800 mg/daily po ; 100 mg/daily po ; 200 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1999-06-19
End date: 1999-10-31
Norvir
Dosage: 400 mg/bid po ; 800 mg/daily po ; 100 mg/daily po ; 200 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2008-09-20
Norvir
Dosage: 400 mg/bid po ; 800 mg/daily po ; 100 mg/daily po ; 200 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2008-09-19
Norvir
Dosage: 400 mg/bid po ; 800 mg/daily po ; 100 mg/daily po ; 200 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-12-24
Videx
Dosage: 400 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2001-07-21
End date: 2004-05-14
Videx
Dosage: 125 mg/bid po ; 300 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1994-12-19
End date: 1997-03-07
Videx
Dosage: 125 mg/bid po ; 300 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1997-03-07
End date: 2001-07-21
Zerit
Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1998-02-27
End date: 1998-08-03
Zerit
Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1997-08-25
End date: 1998-02-27
Zerit
Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1998-08-03
End date: 1998-11-09
Zerit
Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 1998-11-09
End date: 1999-06-19
Zerit
Dosage: 30 mg/bid po ; 40 mg/bid po ; 30 mg/bid po ; 40 mg/bid po ; 80 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-12-25
End date: 2001-10-20
Ziagen
Dosage: 600 mg/daily po ; 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-07-24
End date: 2000-07-25
Ziagen
Dosage: 600 mg/daily po ; 600 mg/daily po
Administration route: Oral
Indication: HIV Infection
Start date: 2001-10-20
End date: 2001-10-27
Other drugs received by patient: Antihemophilic Factor (Human)
Possible Kaletra side effects in male
Reported by a lawyer from France on 2011-12-05
Patient: male
Reactions: Confusional State, Blood Creatine Phosphokinase Increased, Dreamy State, Quality of Life Decreased, Coma, Corneal Disorder, Eye Infection, Abdominal Pain Upper, Overdose, Bronchial Disorder, Hypoxia, Oral Mucosa Erosion, Stevens-Johnson Syndrome, Renal Disorder, Toxic Epidermal Necrolysis, Nosocomial Infection, Odynophagia, Cardiogenic Shock, Eye Pain, Anxiety, Lung Disorder, Dysuria, Pharyngeal Erosion, DRY Eye
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Dosage: 200/50mg (unit dose)
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-05
End date: 2008-02-28
Truvada
Dosage: 200mg/245mg (unit dose)
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-05
End date: 2008-02-28
Other drugs received by patient: Maraviroc; Enfuvirtide; Magnesium Hydroxide TAB; Aspirin; PPI; Gaviscon; Raltegravir; Acetaminophen; Primperan TAB
Possible Kaletra side effects in male
Reported by a physician from Mexico on 2011-11-28
Patient: male
Reactions: Weight Decreased, Drug Resistance, Dyslipidaemia, Diarrhoea, Kaposi's Sarcoma, Faecal Incontinence
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Truvada; Calcium Carbonate; Enterogermina
Possible Kaletra side effects in male
Reported by a individual with unspecified qualification from United States on 2011-11-23
Patient: male, weighing 68.0 kg (149.7 pounds)
Reactions: Weight Decreased, Nausea, Paraesthesia, Burning Sensation, Fatigue, Neuropathy Peripheral, Diarrhoea, Peroneal Nerve Palsy, Gait Disturbance, Lethargy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Kaletra
Dosage: 200 - 50 mg 1 tab q day po
Administration route: Oral
Indication: Injury Associated With Device
Start date: 2011-06-03
End date: 2011-07-02
Truvada
Dosage: 200 - 300 mg 2 tabs bid po
Administration route: Oral
Indication: Injury Associated With Device
Start date: 2011-06-03
End date: 2011-07-02
Possible Kaletra side effects in male
Reported by a lawyer from France on 2011-11-04
Patient: male
Reactions: Quality of Life Decreased, Coma, Corneal Disorder, Eye Infection, Stevens-Johnson Syndrome
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kaletra
Dosage: 200/50mg (unit dose)
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-05
End date: 2008-02-28
Truvada
Dosage: 200mg/245mg (unit dose)
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-05
End date: 2008-02-28
Other drugs received by patient: Raltegravir; Maraviroc; Enfuvirtide
|
